Nate W. Oswald

Urology

819 E Market Place Dr Ste D
Spanish Fork, UT 84660

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 01, 2023

Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.

Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 03, 2022

Factors associated with appropriate and low-value PSA testing.

Factors associated with appropriate and low-value PSA testing.

Journal: Cancer epidemiology

Published: September 30, 2019

Showing 1-3 of 3

Last Updated: 09/26/2026